Sutton Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Sutton Wealth Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-126	Closed	-$2.26K	–	1074
2016 Q4	$2.26K	Hold	126	–	–	﹤0.01%	921
2016 Q3	$2.62K	Hold	126	–	–	﹤0.01%	901
2016 Q2	$3.39K	Hold	126	–	–	﹤0.01%	846
2016 Q1	$3.41K	Buy	+126	New	+$3.38K	﹤0.01%	831

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Sutton Wealth Advisors's NVO Position: Q1 2017 in Review

Sutton Wealth Advisors sold out of Novo Nordisk (NVO) in Q1 2017, closing a stake of 126 shares — an estimated $2.26K sold.

Sutton Wealth Advisors first reported a position in NVO in Q1 2016 and held it in 4 quarters. The position peaked at $3.41K in Q1 2016. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

Sutton Wealth Advisors reported no remaining Novo Nordisk position as of Q1 2017 after selling out during the quarter.
Sutton Wealth Advisors sold 126 Novo Nordisk shares in Q1 2017, an estimated $2.26K.
Sutton Wealth Advisors first reported a position in Novo Nordisk in Q1 2016 and held it in 4 quarters.
Sutton Wealth Advisors's Novo Nordisk position peaked at $3.41K in Q1 2016.
463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on Sutton Wealth Advisors's 13F filing for Q1 2017, filed 6 Nov 2023.